FDA-approved GLP-1 receptor agonist medications containing semaglutide (such as Wegovy and Ozempic) have been shown in clinical studies to support weight management and blood sugar control when used as directed, combined with diet and exercise
Patients should contact their healthcare provider if they experience severe or persistent heartburn that does not respond to conservative measures or over-the-counter treatments within 1-2 weeks, as this may indicate more significant gastroesophageal pathology requiring investigation
Storage conditions Store in a cool, dry place and away from sunlight
Yet the responses circulating in mainstream spaces are often reductivelike just take this drug or ditch the carbsmissing the individual context, lived experience, and long-term sustainability that real health conversations deserve
The letters posted Tuesday come from FDA's drug center
The effect of IGF-1 on the closure process of processus vaginalis [PMID: 41486112] Laboratory literature summary: The effect of IGF-1 on the closure process of processus vaginalis